ATE406578T1 - Candida-nachweis - Google Patents

Candida-nachweis

Info

Publication number
ATE406578T1
ATE406578T1 AT02717869T AT02717869T ATE406578T1 AT E406578 T1 ATE406578 T1 AT E406578T1 AT 02717869 T AT02717869 T AT 02717869T AT 02717869 T AT02717869 T AT 02717869T AT E406578 T1 ATE406578 T1 AT E406578T1
Authority
AT
Austria
Prior art keywords
candida
proof
present
relates
candida infection
Prior art date
Application number
AT02717869T
Other languages
English (en)
Inventor
John Warmington
Denis Ballantyne
Original Assignee
Rockeby Biomed Australia Pty L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rockeby Biomed Australia Pty L filed Critical Rockeby Biomed Australia Pty L
Application granted granted Critical
Publication of ATE406578T1 publication Critical patent/ATE406578T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/40—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Candida
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/37—Assays involving biological materials from specific organisms or of a specific nature from fungi
    • G01N2333/39—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts
    • G01N2333/40—Assays involving biological materials from specific organisms or of a specific nature from fungi from yeasts from Candida

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT02717869T 2001-04-25 2002-04-23 Candida-nachweis ATE406578T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/841,188 US6916626B1 (en) 2001-04-25 2001-04-25 Detection of Candida

Publications (1)

Publication Number Publication Date
ATE406578T1 true ATE406578T1 (de) 2008-09-15

Family

ID=25284255

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02717869T ATE406578T1 (de) 2001-04-25 2002-04-23 Candida-nachweis

Country Status (9)

Country Link
US (5) US6916626B1 (de)
EP (1) EP1381864B1 (de)
JP (1) JP3969722B2 (de)
CN (1) CN1505759A (de)
AT (1) ATE406578T1 (de)
AU (1) AU2002248996B2 (de)
CA (1) CA2445430A1 (de)
DE (1) DE60228557D1 (de)
WO (1) WO2002088741A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US20050266499A1 (en) * 2001-04-25 2005-12-01 Rockeby Biomed Corporation, Ltd. Method and apparatus for testing for presence or absence of select biological substances
ITMI20030643A1 (it) 2003-04-01 2004-10-02 Copan Innovation Ltd Tampone per il prelievo di campioni biologici
US7846676B2 (en) * 2004-07-19 2010-12-07 Cell Biosciences, Inc. Methods and devices for analyte detection
US7935479B2 (en) 2004-07-19 2011-05-03 Cell Biosciences, Inc. Methods and devices for analyte detection
DE602005025414D1 (de) * 2005-04-30 2011-01-27 Beijing Threeman Medicine Science And Technology Ltd Company Immunnachweiskit in verbindung mit neuroglobin-enzym sowie verwendung davon
WO2006133434A2 (en) * 2005-06-08 2006-12-14 Board Of Regents, The University Of Texas System Membranolytic polypeptides and methods of use
WO2007035864A2 (en) * 2005-09-20 2007-03-29 Cell Biosciences, Inc. Electrophoresis standards, methods and kits
DE102005047384A1 (de) * 2005-09-28 2007-04-05 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Candida-Diagnostik-Chip
WO2008122241A1 (en) * 2007-04-04 2008-10-16 Diagcor Bioscience Incorporation Limited Rapid protein analyses and the device thereof
US10107782B2 (en) 2008-01-25 2018-10-23 ProteinSimple Method to perform limited two dimensional separation of proteins and other biologicals
CA2717036A1 (en) * 2008-02-28 2009-09-03 Martin Thurnher Methods for prognosing the status of tumor patients
EP2096438A1 (de) * 2008-02-28 2009-09-02 Martin Thurnher Verfahren zur Prognose des Status von Patienten
IT1401447B1 (it) * 2010-06-09 2013-07-26 Copan Italia Spa Metodo per il trasferimento quantitativo di analiti
IT1403618B1 (it) 2011-01-05 2013-10-31 Copan Italia Spa Procedimento per realizzare un dispositivo per il prelievo ed il trasferimento di campioni per biologia molecolare
US8735367B2 (en) * 2011-06-27 2014-05-27 University Of Utah Research Foundation Small molecule-dependent split aptamer ligation
EP2839276B1 (de) 2012-04-19 2018-06-27 ProteinSimple Isoelektrische fokussierung mit zwei wellenlängen zur bestimmung der wirkstofflast in antikörper-wirkstoff-konjugaten
US8945838B2 (en) 2012-06-20 2015-02-03 University Of Utah Research Foundation Aptamer-based lateral flow assay and associated methods
US9766206B2 (en) 2013-09-27 2017-09-19 ProteinSimple Apparatus, systems, and methods for capillary electrophoresis
CN103962399B (zh) * 2014-04-08 2016-04-13 中天钢铁集团有限公司 P/f线散卷冷却站
US10457716B2 (en) * 2014-08-06 2019-10-29 University Of Notre Dame Du Lac Protein folding and methods of using same
JP6574713B2 (ja) * 2016-01-20 2019-09-11 国立大学法人信州大学 免疫力検査方法および免疫力検査キット
US11051532B2 (en) 2017-09-22 2021-07-06 Impossible Foods Inc. Methods for purifying protein
WO2019152657A1 (en) 2018-02-03 2019-08-08 Simple Healthkit, Inc. Reliable, comprehensive, and rapid sexual health assessment
CN109085353A (zh) * 2018-06-13 2018-12-25 比杭生物科技（杭州）有限公司 一种白色念珠菌胶体金检测卡及其应用
EP3670646A1 (de) * 2018-12-21 2020-06-24 Ohly GmbH Funktionelles hefeproteinkonzentrat
WO2021100855A1 (ja) * 2019-11-20 2021-05-27 オリンパス株式会社 β－１，３－１，６－グルカンの測定方法
US12011016B2 (en) 2020-09-14 2024-06-18 Impossible Foods Inc. Protein methods and compositions
CN113670907B (zh) * 2021-08-13 2023-06-09 广东海洋大学 一种cgc杂化纳米复合物及其制备方法和应用
CN113791216A (zh) * 2021-08-31 2021-12-14 石家庄和亚生物技术有限公司 一种检测人血清光滑念珠菌烯醇化酶IgG抗体的ELISA检测方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4670382A (en) * 1983-12-02 1987-06-02 Temple University--of the Commonwealth System of Higher Education Monoclonal antibody to Candida albicans cytoplasmic antigens and methods of preparing same
US4806465A (en) * 1984-01-16 1989-02-21 Temple University Of The Commonwealth System Of Higher Education Cytoplasmic antigens of candida albicans and methods of using the same
US4632901A (en) * 1984-05-11 1986-12-30 Hybritech Incorporated Method and apparatus for immunoassays
DE3445816C1 (de) * 1984-12-15 1986-06-12 Behringwerke Ag, 3550 Marburg Flaechenfoermiges diagnostisches Mittel
US5879881A (en) * 1985-04-04 1999-03-09 Hybritech, Incorporated Solid phase system for use in ligand-receptor assays
US4920046A (en) * 1987-02-20 1990-04-24 Becton, Dickinson And Company Process, test device, and test kit for a rapid assay having a visible readout
US4946945A (en) * 1987-06-23 1990-08-07 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5116612A (en) * 1987-06-23 1992-05-26 Allergy Immuno Technologies, Inc. Immunotherapy agents for treatment of IgE mediated allergies
US5521153A (en) * 1987-10-02 1996-05-28 Ciba-Geigy Corporation Synergistic antifungal protein and compositions containing same
US5075078A (en) * 1989-10-05 1991-12-24 Abbott Laboratories Self-performing immunochromatographic device
WO1992012428A1 (en) * 1991-01-11 1992-07-23 Quidel Corporation A one-step lateral flow nonbibulous assay
JP3203268B2 (ja) * 1991-07-12 2001-08-27 デイド・ベーリング・マルブルク・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング カンジダ感染の検出方法
US5786221A (en) * 1991-11-26 1998-07-28 Biomerica, Inc. Diagnostic test for measuring islet cell autoantibodies and reagents relating thereto
GB2270076A (en) * 1992-08-18 1994-03-02 Univ Manchester Human HSP 90 Epitopes
US5545525A (en) 1994-03-07 1996-08-13 Universite De Montreal Detection of candida albicans
US20030008410A1 (en) * 1995-03-13 2003-01-09 Hechinger Mark K. Immunoassay apparatus, kit and methods
US5741662A (en) * 1995-12-18 1998-04-21 Quidel Corporation Direct stain specific binding assays for microorganisms
US5798273A (en) * 1996-09-25 1998-08-25 Becton Dickinson And Company Direct read lateral flow assay for small analytes
US5710005A (en) * 1996-10-29 1998-01-20 Biocode, Inc. Analyte detection with a gradient lateral flow device
US6194221B1 (en) * 1996-11-19 2001-02-27 Wyntek Diagnostics, Inc. Hybrid one-step immunochromatographic device and method of use
US6979576B1 (en) * 1997-07-25 2005-12-27 Shu-Ching Cheng Methods of use of one step immunochromatographic device for Streptococcus A antigen
US5707816A (en) * 1997-02-06 1998-01-13 Immunosciences Lab, Inc. Immunological cross reactivity between Candida and human tissue or food antigens
US6057165A (en) * 1997-02-07 2000-05-02 Becton, Dickinson And Company Quality control procedure for membrane flow-through diagnostic assay devices
JPH11103862A (ja) * 1997-10-01 1999-04-20 Takara Shuzo Co Ltd 抗原タンパク質及び該タンパク質をコードする核酸
US6057127A (en) * 1998-01-29 2000-05-02 Heska Corporation Equine Fc epsilon receptor alpha chain nucleic acid molecules and uses thereof
US6824997B1 (en) * 1998-09-18 2004-11-30 Binax, Inc. Process and materials for the rapid detection of streptococcus pneumoniae employing purified antigen-specific antibodies
US6497880B1 (en) * 1998-12-08 2002-12-24 Stressgen Biotechnologies Corporation Heat shock genes and proteins from Neisseria meningitidis, Candida glabrata and Aspergillus fumigatus
US6875855B1 (en) * 1999-02-26 2005-04-05 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nucleic acid and amino acid sequences of hemoglobin-response genes in candida albicans and the use of reagents derived from these sequences in the diagnosis of disseminated candida albicans infection
CA2399202A1 (en) * 2000-03-09 2001-09-13 Heska Corporation Use of recombinant antigens to determine the immune status of an animal
US20040241876A1 (en) * 2000-12-22 2004-12-02 France Fannes Flow through assay device, diagnostic kit comprising said assay device and use of said assay device in the detection of an analyte present in a sample
US20050266499A1 (en) * 2001-04-25 2005-12-01 Rockeby Biomed Corporation, Ltd. Method and apparatus for testing for presence or absence of select biological substances
US6916626B1 (en) * 2001-04-25 2005-07-12 Rockeby Biomed Ltd. Detection of Candida
US6867004B2 (en) * 2001-12-21 2005-03-15 Focus Technologies, Inc. Methods of using oxidized fungal antigens in antibody testing

Also Published As

Publication number Publication date
JP3969722B2 (ja) 2007-09-05
JP2004529350A (ja) 2004-09-24
CN1505759A (zh) 2004-06-16
WO2002088741A1 (en) 2002-11-07
DE60228557D1 (de) 2008-10-09
EP1381864A1 (de) 2004-01-21
CA2445430A1 (en) 2002-11-07
EP1381864A4 (de) 2004-06-16
US20040166546A1 (en) 2004-08-26
US6916626B1 (en) 2005-07-12
AU2002248996B2 (en) 2004-09-30
US20090030054A1 (en) 2009-01-29
US20080187988A1 (en) 2008-08-07
EP1381864B1 (de) 2008-08-27
US20060105406A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
ATE406578T1 (de) Candida-nachweis
TW200512457A (en) Method of diagnosing SARS corona virus infection
DK1668368T3 (da) Detektion af histon-modifikation i cellefrie nukleosomer
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
ES2316597T8 (es) Instrumentos analíticos, biosensores y métodos
AU2002327037A1 (en) Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
SE0400191D0 (sv) A test kit for detecting periodontal disease
EP1643894A4 (de) Verfahren, kits und antikörper zum nachweis von parathyroid
WO2004015420A8 (en) Method for diagnosing multiple sclerosis
ATE420364T1 (de) Verfahren zur magenkrebsvorhersage
DE60220815D1 (de) Nachweis durch serrs in mikrofluidischer umgebung
SG164389A1 (en) Detection of a therapeutic antibody in an experimental animal
EP1245957A3 (de) Methode zur Konzentrationsbestimmung von Ceruloplasmin in einem Blutflecken mittels enzymgekoppeltem Immunosorbent-Assay oder mittels dissoziationsverstärktem, zeitaufgelöstem Immunofluoreszenzassay, sowie Kit zum Auffinden der Wilson-Krankheit und Diagnosemethode für letztere
ATE427494T1 (de) Verfahren zur quantifizierung der akt-protein- expression
CA2346406A1 (en) Detection of pleiotrophin
NO20052553D0 (no) Cobalaminanalyse.
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
NO20016080D0 (no) Analyse
DE602006003903D1 (de) In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion
ATE511646T1 (de) Diagnose mykobakterieller infektionen mittels bestimmung von ifn-gamma
DE69912453D1 (de) Verfahren und materialien zur diagnose instabiler angina
ATE408827T1 (de) Quantifizierung von stressbelastung
ATE461452T1 (de) Verfahren zum nachweis von menschlichem parvovirus-antigen
DE69531206D1 (de) Methode zur identifizierung von immungeschwächter patienten mit einem hohen risiko für cryptococcosis durch dem igg antikörperstand gegen glucoronoxylomannan zu titrieren
EP1030179A4 (de) Verfahren zum bestimmen humaner thymidylatsynthase und versuchskit

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties